Zhongjian Yu

10PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 22, 2026
Targeting VEGF signaling and stromal remodeling enhances chemoimmunotherapy efficacy in esophageal cancer.

|Jul 02, 2025
Circular RNA circLIMK1-005 promotes the progression of lung adenocarcinoma by interacting with RPA1 protein to activate CDK4 signaling.

Xia Yang, Lu Liu, Zhongjian Yu

|Jul 11, 2024
Synergistic action of gemcitabine and celecoxib in promoting the antitumor efficacy of anti-programmed death-1 monoclonal antibody by triggering immunogenic cell death.

Xiongjie Zhu, Wenkai Zhang, Zhongjian Yu

|Jul 21, 2023
An iRGD-conjugated photothermal therapy-responsive gold nanoparticle system carrying siCDK7 induces necroptosis and immunotherapeutic responses in lung adenocarcinoma.

Rui Cai, Meng Wang, Meiyuan Liu

|Jun 24, 2021
Circular RNA hsa_circ_0110389 promotes gastric cancer progression through upregulating SORT1 via sponging miR-127-5p and miR-136-5p.

Min Liang, Wenxia Yao, Boyun Shi

|Mar 25, 2021
Circ-HMGA2 (hsa_circ_0027446) promotes the metastasis and epithelial-mesenchymal transition of lung adenocarcinoma cells through the miR-1236-3p/ZEB1 axis.

Zhongjian Yu, Xiongjie Zhu, Ying Li

Pageof 2

Frequent Collaborators

1 joint publications

Rui Guo

1 joint publications

Wenxia Yao

1 joint publications

Xinke Zhou

1 joint publications

Jiangyu Zhang